Search Results - "SEARS, CATHERINE R"

Refine Results
  1. 1

    DNA repair targeted therapy: The past or future of cancer treatment? by Gavande, Navnath S, VanderVere-Carozza, Pamela S, Hinshaw, Hilary D, Jalal, Shadia I, Sears, Catherine R, Pawelczak, Katherine S, Turchi, John J

    Published in Pharmacology & therapeutics (Oxford) (01-04-2016)
    “…The repair of DNA damage is a complex process that relies on particular pathways to remedy specific types of damage to DNA. The range of insults to DNA…”
    Get full text
    Journal Article
  2. 2
  3. 3

    DNA repair as an emerging target for COPD-lung cancer overlap by Sears, Catherine R.

    Published in Respiratory investigation (01-03-2019)
    “…Cigarette smoking is the leading cause of lung cancer and chronic obstructive pulmonary disease (COPD). Many of the detrimental effects of cigarette smoke have…”
    Get full text
    Journal Article
  4. 4

    Xeroderma Pigmentosum Complementation Group C (XPC): Emerging Roles in Non-Dermatologic Malignancies by Nasrallah, Nawar Al, Wiese, Benjamin M, Sears, Catherine R

    Published in Frontiers in oncology (21-04-2022)
    “…Xeroderma pigmentosum complementation group C (XPC) is a DNA damage recognition protein essential for initiation of global-genomic nucleotide excision repair…”
    Get full text
    Journal Article
  5. 5

    XPC protects against smoking- and carcinogen-induced lung adenocarcinoma by Zhou, Huaxin, Saliba, Jacob, Sandusky, George E, Sears, Catherine R

    Published in Carcinogenesis (New York) (14-05-2019)
    “…Cigarette smoke (CS) contains hundreds of carcinogens and is a potent inducer of oxidative and bulky DNA damage, which when insufficiently repaired leads to…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Complex Cisplatin-Double Strand Break (DSB) Lesions Directly Impair Cellular Non-Homologous End-Joining (NHEJ) Independent of Downstream Damage Response (DDR) Pathways by Sears, Catherine R., Turchi, John J.

    Published in The Journal of biological chemistry (13-07-2012)
    “…The treatment for advanced stage non-small cell lung cancer (NSCLC) often includes platinum-based chemotherapy and IR. Cisplatin and IR combination therapy…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Recognition of DNA Termini by the C-Terminal Region of the Ku80 and the DNA-Dependent Protein Kinase Catalytic Subunit by Woods, Derek S, Sears, Catherine R, Turchi, John J

    Published in PloS one (15-05-2015)
    “…DNA double strand breaks (DSBs) can be generated by endogenous cellular processes or exogenous agents in mammalian cells. These breaks are highly variable with…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Hemophagocytic Lymphohistiocytosis in the Medical ICU: A Single-Institution Cohort Study on Acute Liver Failure and Mortality by Al Nasrallah, Nawar, Al-Hader, Ahmad, Samala, Niharika, Sears, Catherine R

    Published in Critical care explorations (08-01-2021)
    “…Hemophagocytic lymphohistiocytosis is a life-threatening hyperinflammatory disorder that is associated with high morbidity and mortality in the ICU. It has…”
    Get full text
    Journal Article
  13. 13

    Biomarkers in Lung Cancer by Sears, Catherine R., Mazzone, Peter J.

    Published in Clinics in chest medicine (01-03-2020)
    “…Biomarkers that focus on lung cancer risk assessment, detection, prognosis, diagnosis, and personalized treatment are in various stages of development. This…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    DNA Repair Capacity for Personalizing Risk and Treatment Response − Assay Development and Optimization in Human Peripheral Blood Mononuclear Cells (PBMCs) by Nasrallah, Nawar Al, Zhou, Huaxin, Smith, Patricia A., Sears, Catherine R.

    Published in DNA repair (01-03-2022)
    “…DNA repair capacity (DRC) is the ability of a cell to repair DNA damage. Differential DRC plays an important role in human disease, including lung and other…”
    Get full text
    Journal Article
  18. 18

    Invasive Fungal Infections in the Era of Biologics by Arnold, Tamra M., PharmD, BCPS, Sears, Catherine R., MD, Hage, Chadi A., MD

    Published in Clinics in chest medicine (01-06-2009)
    “…With the advent and widespread use of immunomodulating biologic agents, emerging invasive fungal infections are reported increasingly. To date there is no…”
    Get full text
    Journal Article
  19. 19

    DNA damage response (DDR) pathway engagement in cisplatin radiosensitization of non-small cell lung cancer by Sears, Catherine R., Cooney, Sean A., Chin-Sinex, Helen, Mendonca, Marc S., Turchi, John J.

    Published in DNA repair (01-04-2016)
    “…•Combination cisplatin–radiation causes sequence dependent cytotoxicity in non-small cell lung cancer.•Treatment with combination cisplatin-ionizing radiation…”
    Get full text
    Journal Article
  20. 20